Gritstone Bio Inc (NASDAQ: GRTS) is 37.25% higher on its value in year-to-date trading and has touched a low of $1.14 and a high of $3.33 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GRTS stock was last observed hovering at around $2.59 in the last trading session, with the day’s gains setting it 0.21%.
Currently trading at $2.80, the stock is 12.25% and 13.74% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.01 million and changing 8.11% at the moment leaves the stock 38.60% off its SMA200. GRTS registered 12.90% gain for a year compared to 6-month gain of 133.33%. The firm has a 50-day simple moving average (SMA 50) of $224.72 and a 200-day simple moving average (SMA200) of -$2.36.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.56% loss in the last 1 month and extending the period to 3 months gives it a 36.59%, and is 2.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.39% over the week and 11.26% over the month.
Gritstone Bio Inc (GRTS) has around 231 employees, a market worth around $274.60M and $1.33M in sales. Profit margin for the company is -10397.15%. Distance from 52-week low is 145.76% and -15.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-92.50%).
Gritstone Bio Inc quarterly earnings per share for the current quarter are estimated at -$0.33 with sales reaching $920k over the same period.The EPS is expected to grow by 12.60% this year, but quarterly earnings will post 64.90% year-over-year. Quarterly sales are estimated to shrink -62.30% in year-over-year returns.
124 institutions hold shares in Gritstone Bio Inc (GRTS), with institutional investors hold 44.71% of the company’s shares. The shares outstanding are 97.59M, and float is at 89.41M with Short Float at 9.86%. Institutions hold 43.60% of the Float.
The top institutional shareholder in the company is Point72 Asset Management, L.P. with over 7.57 million shares valued at $14.77 million. The investor’s holdings represent 8.14% of the GRTS Shares outstanding. As of Jun 29, 2023, the second largest holder is Redmile Group, LLC with 6.86 million shares valued at $13.38 million to account for 7.37% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6.21 million shares representing 6.68% and valued at over $12.12 million, while Vanguard Group Inc holds 4.35% of the shares totaling 4.05 million with a market value of $7.9 million.
Gritstone Bio Inc (GRTS) Insider Activity
The most recent transaction is an insider purchase by Economides Vassiliki, the company’s. SEC filings show that Economides Vassiliki bought 12,000 shares of the company’s common stock on May 23 ’23 at a price of $1.90 per share for a total of $22829.0. Following the purchase, the insider now owns 0.21 million shares.
